Multiple endocrine neoplasia 1 (MEN1) syndrome, a disease arising from a genetic
predisposition to tumor development caused by MEN1 loss-of-function mutations, is …

Objectives The pancreatic neuroendocrine tumors (PanNETs) are a group of clinically
heterogeneous neoplasms. Although previous studies illustrated the somatic mutation …

Pancreatic neuroendocrine tumors (PanNETs) are a heterogeneous group of tumors that
exhibit an unpredictable and broad spectrum of clinical presentations and biological …

Human pancreatic neuroendocrine tumors (PanNETs) are a rare, deadly tumor type that is
sporadic or arises in the background of a hereditary syndrome. A critical genetic event in …

Pancreatic neuroendocrine tumors (PanNETs) are complicated and often deadly
neoplasms. A recent increased understanding of their molecular biology has contributed to …

Neuroendocrine neoplasms (NENs) are a relatively rare group of heterogeneous tumours
originating from neuroendocrine cells found throughout the body. Pancreatic NENs …

Purpose We assessed the usefulness of real-time molecular profiling through next-
generation sequencing (NGS) in predicting the tumor biology of advanced pancreatic …

The PanNET Working Group of the 16th International Multiple Endocrine Neoplasia
Workshop (MEN2019) convened in Houston, TX, USA, 27–29 March 2019 to discuss key …

Pancreatic neuroendocrine tumors (PNET) may develop sporadically or in the context of
hereditary syndromes. In patients with multiple endocrine neoplasia type 1 (MEN1), PNET is …

Pancreatic neuroendocrine tumors (PNETs) are rare tumors, categorized as functional and
nonfunctional tumors based on whether they can retain the ability to release hormones such …